Acetylation stabilizes stathmin1 and promotes its activity contributing to gallbladder cancer metastasis
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Gallbladder cancer is the most common biliary tract malignant tumor with highly metastatic characters and poor prognosis. However, the underlying mechanism remains unclear. Stathmin1 is ubiquitous phosphoprotein, regulating microtubule stabilization. We identified the acetylation of stahtmin1 at lysine 9 (K9) in gallbladder cancer. K9 acetylation of stathmin1 was reversely regulated by the acetyltransferase PCAF and the deacetylases sirt2. K9 acetylation of stathmin1 inhibited the combining of stathmin1 to E3 ubiquitin ligase RLIM, thereby inhibiting its ubiquitination degradation. Moreover, K9 acetylation also promoted the activity of stahtmin1 interacting and destabilizing microtubule through the inhibition of stathmin1 phosphorylation. K9 acetylated stathmin1 significantly promoted gallbladder cancer cell migration and invasion viability in vitro and lung metastasis in vivo, and indicated poor prognosis of nude mice. IHC assay suggested the positive correlation of high levels of K9 acetylation and stathmin1 expression in gallbladder cancer. Our study revealed that K9 acetylation up-regulated stathmin1 protein stability and microtubule-destabilizing activity to promoted gallbladder cancer metastasis, which provides a potential target for gallbladder cancer therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Accordingly, gallbladder cancer mouse models expressing stathmin 1K9R show reduced cell migration [94].”
From Acetylation: a new target for protein degradation in cancer (2025) · cites this paper as [94]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“This finding, along with evidence showing increased stathmin 1K9Ac levels in gallbladder cancer patient tissue, suggests that stathmin 1K9Ac promotes metastasis in gallbladder cancer [94].”
From Acetylation: a new target for protein degradation in cancer (2025) · cites this paper as [94]
The cited source says what the claim attributes to it.
In the citing paper
“Stathmin 1K9Ac also reduces stathmin 1 phosphorylation at position 25, which cooperates with MAPK signaling [94].”
From Acetylation: a new target for protein degradation in cancer (2025) · cites this paper as [94]
The cited source says what the claim attributes to it.
In the citing paper
“This finding, along with evidence showing increased stathmin 1K9Ac levels in gallbladder cancer patient tissue, suggests that stathmin 1K9Ac promotes metastasis in gallbladder cancer [94].”
From Acetylation: a new target for protein degradation in cancer (2025) · cites this paper as [94]
The cited source says what the claim attributes to it.
In the citing paper
“Stathmin 1 is acetylated at K9 (modulated by PCAF and SIRT2), which reduces its interaction with E3 ligase RLIM and therefore inhibits ubiquitination and degradation of stathmin 1 (Figure 4A) [94].”
From Acetylation: a new target for protein degradation in cancer (2025) · cites this paper as [94]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lysine acetylation targets protein complexes and co-regulates major cellular functions
Choudhary, C., Kumar, C., Gnad, F., Nielsen, M. L., Rehman, M., Walther, T. C., Olsen, J. V., & Mann, M. (2009) · Science · doi:10.1126/science.1175371 · Cited by 4,040 · cited 4×
“The mass spectrum data indicated potential acetylation of stathmin1 [17].”
BackgroundInfluential(2012) · Hepatogastroenterology · doi:10.5754/hge12404 · Cited by 1,825
Targeting bromodomains: epigenetic readers of lysine acetylation
Filippakopoulos, P., & Knapp, S. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4286 · Cited by 1,243
The world of protein acetylation
Drazic, A., Myklebust, L. M., Ree, R., & Arnesen, T. (2016) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2016.06.007 · Cited by 804
Lv, L., Li, D., Zhao, D., Lin, R., Chu, Y., Zhang, H., Zha, Z., Liu, Y., Li, Z., Xu, Y., et al. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.04.025 · Cited by 610
Microtubules in Cell Migration
Etienne-Manneville, S. (2013) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-101011-155711 · Cited by 508
Immunoaffinity Enrichment and Mass Spectrometry Analysis of Protein Methylation
Guo, A., Gu, H., Zhou, J., Mulhern, D., Wang, Y., Lee, K. A., Yang, V., Aguiar, M., Kornhauser, J., Jia, X., et al. (2014) · Molecular & Cellular Proteomics · doi:10.1074/mcp.o113.027870 · Cited by 474
Jiang, W., Wang, S., Xiao, M., Lin, Y., Zhou, L., Lei, Q., Xiong, Y., Guan, K.-L., & Zhao, S. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.04.028 · Cited by 415
Acetylation stabilizes ATP-citrate lyase to promote lipid biosynthesis and tumor growth
Lin, R., Tao, R., Gao, X., Li, T., Zhou, X., Guan, K.-L., Xiong, Y., & Lei, Q.-Y. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.07.002 · Cited by 384
Regulation of intermediary metabolism by protein acetylation
Guan, K.-L., & Xiong, Y. (2011) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2010.09.003 · Cited by 350
Research works printed but not linked: 2
- Chen S, Zhao Y, Shen F, Long D, Yu T, Lin X. Introduction of exogenous wildtype p53 mediates the regulation of oncoprotein 18/stathmin signaling via nuclear factorkappaB in nonsmall cell lung cancer NCIH1299 cells. Oncol Rep. 2019;41:2051–9.
- Zhao Y, Chen S, Shen F, Long D, Yu T, Wu M, et al. In vitro neutralization of autocrine IL10 affects Op18/stathmin signaling in nonsmall cell lung cancer cells. Oncol Rep. 2019;41:501–11.
Cited by
Non-lysine ubiquitylation: Doing things differently
Kelsall, I. R. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.1008175 · Cited by 83
Acetylation: a new target for protein degradation in cancer
Crawford, C. E. W., & Burslem, G. M. (2025) · Trends in Cancer · doi:10.1016/j.trecan.2025.01.013 · Cited by 20
siRNA-based strategies to combat drug resistance in gastric cancer
Khaleel, A. Q., Alshahrani, M. Y., Rizaev, J. A., Malathi, H., Devi, S., Pramanik, A., Mustafa, Y. F., Hjazi, A. M., Muazzamxon, I., & Husseen, B. (2024) · Medical Oncology · doi:10.1007/s12032-024-02528-w · Cited by 13
Inhibition of 14-3-3ε by K50 acetylation activates YAP1 to promote cholangiocarcinoma growth
Fan, K., Zhu, K., Wang, J., Ni, X., Shen, S., Gong, Z., Cheng, X., Zhang, C., Liu, H., Suo, T., et al. (2022) · Experimental Cell Research · doi:10.1016/j.yexcr.2022.113404 · Cited by 6
Self-citationReversible Acetylation of Non-histone Proteins in Human Cancers
Feng, C., Zeng, Y., Prochownik, E. V., Jiang, C., & Li, Y. (2025) · Results and problems in cell differentiation · doi:10.1007/978-3-031-91459-1_13 · Cited by 1
Metadata
- Authors
- Fan, K., Ni, X., Shen, S., Gong, Z., Wang, J., Xin, Y., Zheng, B., Sun, W., Liu, H., Suo, T., Ni, X., & Liu, H.
- Affiliations
- Shanghai Medical College of Fudan University (CN)
- Corresponding author
- Ni, Xiaoling
- Liu, Houbao
- ORCID
- Venue
- Cell Death Discovery
- Published
- 2022-05-17
- Volume
- 8
- Issue
- 1
- Pages
- 265-265
- ISSN
- 2058-7716 (ISSN-L)
- PMC
- PMC9114396
- OpenAlex
- W4280491331
- Cited by
- 6
- References
- 39
- Citations by year
- 2025: 3 · 2024: 1 · 2022: 2
- FWCI
- 1.43
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Cell Death Discovery (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- National Natural Science Foundation of China (81802751, 82072682)
- Natural Science Foundation of Shanghai (22ZR1457800)
- JianFeng Project of XuHui Provincial Commission of Health and Family Planning
- Topics
- Health Sciences › Medicine › Surgery › Cholangiocarcinoma and Gallbladder Cancer Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Health Sciences › Medicine › Gastroenterology › Gallbladder and Bile Duct Disorders
- Keywords
- gallbladder cancer, metastasis, PCAF, SIRT2, RLIM, ubiquitination, protein stability, microtubule destabilization, cell migration and invasion, lung metastasis, prognosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Acetylation stabilizes stathmin1 and promotes its activity contributing to gallbladder cancer metastasis. https://app.cochat.ai/papers/10.1038/s41420-022-01051-z
- The paper
- Fan, K., Ni, X., Shen, S., Gong, Z., Wang, J., Xin, Y., Zheng, B., Sun, W., Liu, H., Suo, T., Ni, X., & Liu, H. (2022). Acetylation stabilizes stathmin1 and promotes its activity contributing to gallbladder cancer metastasis. Cell Death Discovery. https://doi.org/10.1038/s41420-022-01051-z
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.